Kyowa Kirin Co., Ltd. (KYKOF)
USD 16.05
(0.0%)
USD 16.05
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 81.18 Billion JPY | 51.55% |
| 2022 | 53.57 Billion JPY | 2.34% |
| 2021 | 52.34 Billion JPY | 11.31% |
| 2020 | 47.02 Billion JPY | -29.9% |
| 2019 | 67.08 Billion JPY | 23.28% |
| 2018 | 54.41 Billion JPY | 26.84% |
| 2017 | 42.89 Billion JPY | 129.79% |
| 2016 | 18.66 Billion JPY | -37.3% |
| 2015 | 29.77 Billion JPY | 87.28% |
| 2014 | 15.89 Billion JPY | -47.14% |
| 2013 | 30.07 Billion JPY | 24.29% |
| 2012 | 24.19 Billion JPY | -5.5% |
| 2011 | 25.6 Billion JPY | 15.37% |
| 2010 | 22.19 Billion JPY | 0.0% |
| 2009 | - JPY | -100.0% |
| 2008 | 23.47 Billion JPY | 84.95% |
| 2007 | 12.69 Billion JPY | -21.99% |
| 2006 | 16.27 Billion JPY | -9.25% |
| 2005 | 17.93 Billion JPY | 79.02% |
| 2004 | 10.01 Billion JPY | 18.06% |
| 2003 | 8.48 Billion JPY | 53.3% |
| 2002 | 5.53 Billion JPY | -41.09% |
| 2001 | 9.39 Billion JPY | -16.67% |
| 2000 | 11.27 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 14.63 Billion JPY | -47.05% |
| 2024 Q2 | 23.14 Billion JPY | 58.17% |
| 2023 Q4 | 27.63 Billion JPY | -13.39% |
| 2023 FY | 81.18 Billion JPY | 51.55% |
| 2023 Q1 | 12.76 Billion JPY | 192.59% |
| 2023 Q3 | 31.9 Billion JPY | 259.08% |
| 2023 Q2 | 8.88 Billion JPY | -30.36% |
| 2022 FY | 53.57 Billion JPY | 2.34% |
| 2022 Q3 | 14.19 Billion JPY | -25.2% |
| 2022 Q4 | 4.36 Billion JPY | -69.28% |
| 2022 Q1 | 16.03 Billion JPY | -17.5% |
| 2022 Q2 | 18.97 Billion JPY | 18.33% |
| 2021 Q3 | 7.83 Billion JPY | -35.52% |
| 2021 FY | 52.34 Billion JPY | 11.31% |
| 2021 Q1 | 12.92 Billion JPY | 35.47% |
| 2021 Q2 | 12.15 Billion JPY | -5.95% |
| 2021 Q4 | 19.43 Billion JPY | 148.07% |
| 2020 Q2 | 13.95 Billion JPY | 0.82% |
| 2020 Q3 | 9.69 Billion JPY | -30.56% |
| 2020 Q4 | 9.53 Billion JPY | -1.58% |
| 2020 Q1 | 13.84 Billion JPY | 28.57% |
| 2020 FY | 47.02 Billion JPY | -29.9% |
| 2019 Q3 | 8.25 Billion JPY | -79.34% |
| 2019 Q1 | 8.11 Billion JPY | 15.96% |
| 2019 FY | 67.08 Billion JPY | 23.28% |
| 2019 Q2 | 39.95 Billion JPY | 392.36% |
| 2019 Q4 | 10.76 Billion JPY | 30.42% |
| 2018 Q2 | 12.26 Billion JPY | -44.26% |
| 2018 FY | 54.41 Billion JPY | 26.84% |
| 2018 Q4 | 6.99 Billion JPY | -46.77% |
| 2018 Q3 | 13.14 Billion JPY | 7.17% |
| 2018 Q1 | 22 Billion JPY | -4.95% |
| 2017 Q4 | 23.15 Billion JPY | 153.98% |
| 2017 Q3 | 9.11 Billion JPY | 9.41% |
| 2017 FY | 42.89 Billion JPY | 129.79% |
| 2017 Q2 | 8.33 Billion JPY | -1.8% |
| 2017 Q1 | 8.48 Billion JPY | 285.64% |
| 2016 Q3 | 5.7 Billion JPY | 69.62% |
| 2016 Q1 | 7.39 Billion JPY | 98.36% |
| 2016 Q4 | 2.2 Billion JPY | -61.44% |
| 2016 FY | 18.66 Billion JPY | -37.3% |
| 2016 Q2 | 3.36 Billion JPY | -54.53% |
| 2015 Q2 | 4.91 Billion JPY | 6.71% |
| 2015 FY | 29.77 Billion JPY | 87.28% |
| 2015 Q4 | 3.73 Billion JPY | -77.42% |
| 2015 Q3 | 16.52 Billion JPY | 236.07% |
| 2015 Q1 | 4.6 Billion JPY | 19.29% |
| 2014 Q2 | 2.85 Billion JPY | -54.94% |
| 2014 Q4 | 3.86 Billion JPY | 35.46% |
| 2014 FY | 15.89 Billion JPY | -47.14% |
| 2014 Q3 | 2.85 Billion JPY | -0.07% |
| 2014 Q1 | 6.33 Billion JPY | -6.26% |
| 2013 Q3 | 5.64 Billion JPY | -21.48% |
| 2013 Q2 | 7.18 Billion JPY | -31.46% |
| 2013 FY | 30.07 Billion JPY | 24.29% |
| 2013 Q1 | 10.48 Billion JPY | 19.75% |
| 2013 Q4 | 6.75 Billion JPY | 19.66% |
| 2012 Q3 | 3.91 Billion JPY | 30.18% |
| 2012 Q2 | 3 Billion JPY | -64.66% |
| 2012 FY | 24.19 Billion JPY | -5.5% |
| 2012 Q1 | 8.51 Billion JPY | 189.99% |
| 2012 Q4 | 8.75 Billion JPY | 123.62% |
| 2011 Q1 | 14.78 Billion JPY | 89.97% |
| 2011 Q3 | 4.95 Billion JPY | 68.96% |
| 2011 Q2 | 2.93 Billion JPY | -80.17% |
| 2011 FY | 25.6 Billion JPY | 15.37% |
| 2011 Q4 | 2.93 Billion JPY | -40.73% |
| 2010 Q1 | 6.05 Billion JPY | 0.0% |
| 2010 Q3 | 4.51 Billion JPY | 17.31% |
| 2010 Q4 | 7.78 Billion JPY | 72.46% |
| 2010 Q2 | 3.84 Billion JPY | -36.44% |
| 2010 FY | 22.19 Billion JPY | 0.0% |
| 2009 Q2 | 5.69 Billion JPY | 0.0% |
| 2009 FY | - JPY | -100.0% |
| 2009 Q3 | 5.11 Billion JPY | -10.3% |
| 2008 Q2 | 9.58 Billion JPY | 0.0% |
| 2008 Q3 | -1.3 Billion JPY | -113.58% |
| 2008 FY | 23.47 Billion JPY | 84.95% |
| 2007 FY | 12.69 Billion JPY | -21.99% |
| 2006 FY | 16.27 Billion JPY | -9.25% |
| 2005 FY | 17.93 Billion JPY | 79.02% |
| 2004 FY | 10.01 Billion JPY | 18.06% |
| 2003 FY | 8.48 Billion JPY | 53.3% |
| 2002 FY | 5.53 Billion JPY | -41.09% |
| 2001 FY | 9.39 Billion JPY | -16.67% |
| 2000 FY | 11.27 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AstraZeneca PLC | 5.95 Billion USD | -1263.359% |
| Bristol-Myers Squibb Company PFD CONV 2 | 8.02 Billion USD | -911.688% |
| CSPC Pharmaceutical Group Limited | 830.91 Million USD | -9670.9% |
| Clarus Therapeutics Holdings, Inc. | -56.51 Million USD | 143765.062% |
| Novartis AG | 14.85 Billion USD | -446.721% |
| PT Kalbe Farma Tbk. | 179.7 Million USD | -45078.351% |